Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData
Wegovy injections are among the most advanced and effective weight loss treatments available today, offering hope to those struggling with obesity who prefer a non-surgical solution
It may also support immune function and detoxification processes
The patient characteristics have been previously reported (Lin et al, 2022)
A new wave of next-gen anti-obesity drugs is already in development, promising even greater efficacy and different mechanisms of action
Verberk, I
US$ 28.17
:max_bytes(150000):strip_icc()/Simple-7-Day-GLP-1-Friendly-Meal-Plan-for-Beginners-Created-by-a-Dietitian-69f3d02b6c2c41928135df7f0c417552.jpg)
US$ 25.60
US$ 28.21
US$ 28.26
US$ 26.34
US$ 21.94
